Rheumatoid arthritis

Machine learning-based multiclass model for autoimmune disease diagnosis and classification through nailfold videocapillaroscopy features

RMD OpenPublished Diagnostic accuracy study

Authors' conclusion

This study developed a robust multiclassification model for differentiating autoimmune diseases using NVC features.

Study context

Population
Controls and patients with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE) with nailfold videocapillaroscopy (NVC) images
Participants
600 NVC images
Comparison
NVC-feature model distinguishing controls, RA and SLE
  • Controls (Ctr)n = 117reference
  • RAn = 337
  • SLEn = 146
Outcome
Discrimination of Ctr, RA and SLE by NVC features (macro AUC)
Methodological detailsmachine learning, eXtreme Gradient Boosting multiclassification model, SHAP analysis, training and test sets at a 7:3 ratio
  • Machine learning
  • eXtreme Gradient Boosting multiclassification model
  • SHAP analysis
  • Training and test sets at a 7:3 ratio

Performance

As reported in the abstract

Macro AUC of the multiclass model

Macro AUC, training set

0.96

Macro AUC, test set

0.80

Further findings

NVC features differing among groups

NVC features with significant differences among the groups (of 9)
7
Key features by SHAP: papilla shape, RBC aggregation, number of capillary loops, number of crossed capillary loops, subpapillary venous plexus (SVP)

Group-specific NVC patterns

Ctr: papilla shape key feature, correlated with neutrophils, white blood cells and monocytes
RA: number of crossed capillary loops most prominent, correlated with ESR, C3 and C4 and inversely with IgG
SLE: SVP dominant feature, effectively distinguished SLE from Ctr and RA

Original publication

Machine learning-based multiclass model for autoimmune disease diagnosis and classification through nailfold videocapillaroscopy features. RMD Open. Published 4 March 2026. doi:10.1136/rmdopen-2025-006393

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.